Emergent BioSolutions Inc.
EBS | NYSE
$6.55
-$0.25 (-3.68%)
At close: Sep 21, 2026, 4:00 PM ET
$6.55
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:18 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -176.8M | -8.6M | 52.6M | 75.9M | 139.5M | -131.6M | -190.6M | -208.8M | -587M | -565.2M | -760.4M | -798.9M | -620M | -415.1M | -232.6M | 44.7M | 96.5M | 157.5M | 230.9M | 227M | 299.2M | 387.3M |
Depreciation & Amortization | 94.4M | 93.9M | 95.8M | 98.3M | 101.3M | 106.3M | 108.8M | 112.4M | 114M | 118.4M | 126.2M | 132.2M | 136.4M | 148M | 143.2M | 136.8M | 137.3M | 126M | 123.8M | 123.5M | 119.6M | 115M |
Stock-Based Compensation | 18.9M | 16.6M | 16.2M | 15.2M | 12.7M | 13.6M | 18M | 17.7M | 19.4M | 13.9M | 8M | 15.7M | 22.9M | 35.2M | 45.1M | 43.5M | 42.7M | 41.8M | 42.4M | 42.3M | 41.9M | 54.9M |
Other Working Capital | 16.3M | 14.3M | -9.2M | -22.7M | -10.2M | 173.4M | 170.6M | 170.7M | 134.2M | -60.2M | -58.6M | 30.7M | 21.3M | 13.5M | -54.8M | -92.2M | -96.5M | -99M | -61.7M | -29.6M | -89.4M | -18.2M |
Other Non-Cash Items | 171.7M | 28.7M | 32.4M | 19.2M | -53.4M | 29M | 39.3M | 39.2M | 324.8M | 494.9M | 497.9M | 492.5M | 282.1M | 25M | 19.8M | -44.9M | 33.8M | 30M | 33.5M | 92.6M | 61M | 63.3M |
Deferred Income Tax | -11.1M | -27.1M | -4M | -5.9M | 11.6M | 25.3M | -5.5M | -10.3M | -14.9M | -16.5M | -9M | -45.8M | -25.6M | -23.1M | -16.5M | 71.8M | 52.7M | 50.5M | 46.9M | 2.6M | -1.9M | 100K |
Change in Working Capital | -71.7M | 44.5M | -22.4M | -189.7M | -42.7M | 67.5M | 88.7M | 220.5M | 220.7M | -130.4M | -69M | 58.7M | -75.4M | 49.2M | 6.9M | -49.8M | -70.2M | -127.1M | -156.4M | -250.8M | -194.1M | -137.3M |
Operating Cash Flow | 25.4M | 148M | 170.6M | 13M | 169M | 110.1M | 58.7M | 170.7M | 77M | -84.9M | -206.3M | -145.6M | -279.6M | -180.8M | -34.1M | 202.1M | 292.8M | 278.7M | 321.1M | 237.2M | 325.7M | 483.3M |
Capital Expenditures | -11.8M | -12.6M | -13.8M | -11.6M | -14M | -15.7M | -22.9M | -32.6M | -39.4M | -47.3M | -51.6M | -85.6M | -100.9M | -120.5M | -137.6M | -138.9M | -166.2M | -201.1M | -225M | -214.3M | -204.8M | -172.9M |
Cash Acquisitions | n/a | n/a | n/a | 300K | 300K | 300K | 300K | n/a | n/a | 270.2M | 270.2M | 270.2M | 270.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -50.2M | 20.1M | 83.2M | 113.2M | 231M | 210.9M | 147.8M | 117.8M | -6.3M | -6.3M | -6.3M | -28.1M | -265.5M | -265.5M | -265.5M | -243.7M | n/a | n/a | n/a | n/a | n/a | -10M |
Investing Cash Flow | -62M | 7.5M | 69.4M | 101.9M | 217.3M | 195.5M | 125.2M | 85.2M | -45.7M | 216.6M | 212.3M | 178.3M | -74.4M | -364.2M | -381.3M | -382.6M | -166.2M | -201.1M | -225M | -214.3M | -204.8M | -182.9M |
Debt Repayment | -112.5M | -112.5M | -112.5M | -6.9M | -194M | -245.4M | -204.3M | -200.2M | -49.1M | -493.9M | -543.4M | -196M | -161.5M | 326.3M | 326.2M | -33.7M | -30.9M | -28.2M | -35.9M | -33.2M | 66.6M | 69.5M |
Common Stock Repurchased | -35.8M | -33.9M | -24.9M | -15.8M | -6.9M | n/a | -400K | -400K | -500K | -500K | -100K | -300K | -500K | -24.9M | -82.4M | -188.5M | -188.2M | -163.8M | -106.3M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -27.9M | -3.7M | -1.4M | -1.3M | 3.4M | 3.4M | 3.9M | 4.6M | 100K | 100K | -2M | -600K | 237.5M | 239.8M | 237.4M | 236.6M | -13.3M | 16.5M | -15M | -12.6M | -7.8M | -32.2M |
Financial Cash Flow | -174.8M | -147.6M | -136.6M | -22.2M | -186.6M | -231.1M | -190M | -185.8M | -48.5M | -484.5M | -535.7M | -187.3M | 85M | 541.2M | 481.2M | 18.1M | -216.2M | -189.3M | -141M | -33.3M | 58.8M | 67.3M |
Net Cash Flow | -211.6M | 8.7M | 103.5M | 92.8M | 200M | 73.8M | -6.1M | 68.6M | -17.6M | -351.2M | -530.9M | -153.2M | -269.7M | -5.8M | 66.3M | -163M | -89.4M | -112M | -45.2M | -11.2M | 178.7M | 366.3M |
Free Cash Flow | 13.6M | 135.4M | 156.8M | 1.4M | 155M | 94.4M | 35.8M | 138.1M | 37.6M | -132.2M | -257.9M | -231.2M | -380.5M | -301.3M | -171.7M | 63.2M | 126.6M | 77.6M | 96.1M | 22.9M | 120.9M | 310.4M |
Adj. Free Cash Flow | -5.3M | 118.8M | 140.6M | -13.8M | 142.3M | 80.8M | 17.8M | 120.4M | 18.2M | -146.1M | -265.9M | -246.9M | -403.4M | -336.5M | -216.8M | 19.7M | 83.9M | 35.8M | 53.7M | -19.4M | 79M | 255.5M |
Maintenance CapEx | -11.8M | -12.6M | -13.8M | -11.6M | -8.2M | -9.9M | -6.3M | -16M | -16M | -11.4M | -26.5M | -60.5M | -88.4M | -120.5M | -137.6M | -92.2M | -119.5M | -152.87M | -120.67M | -120.67M | -68M | -2.52M |
Growth CapEx | n/a | n/a | n/a | n/a | -5.8M | -5.8M | -16.6M | -16.6M | -23.4M | -35.9M | -25.1M | -25.1M | -12.5M | n/a | n/a | -46.7M | -46.7M | -48.23M | -104.33M | -93.63M | -136.8M | -170.38M |
Owner Earnings | 13.6M | 135.4M | 156.8M | 1.4M | 160.8M | 100.2M | 52.4M | 154.7M | 61M | -96.3M | -232.8M | -206.1M | -368M | -301.3M | -171.7M | 109.9M | 173.3M | 125.83M | 200.43M | 116.53M | 257.7M | 480.78M |
Add to Watchlist
Select watchlists to add or remove EBS